Study of ALV003 in Healthy Adult Volunteers and Subjects With Well-Controlled Celiac Disease Following a Gluten-Containing Meal

Completed · Phase 1 · Has a placebo group

Conditions studied: Celiac Disease

In brief

ALV003-0812 is a study of the safety and tolerability of a study drug (ALV003) in healthy adult volunteers and in patients with well-controlled celiac disease, following a meal that contains gluten.

Key facts

Study ID
NCT00669825
Run by
Alvine Pharmaceuticals Inc.
People needed
36
Starts
2008-03-01
Expected to finish
2008-10-01
Last updated by the study team
2010-02-19

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.